Vertex Pharmaceuticals recently obtained approval for its non-opioid pain medication. The drug could become a blockbuster and a key part of Vertex's portfolio. The stock has been rising in value ...

Obtaining approval from the U.S. Food and Drug Administration (FDA) for a key medication can be a huge catalyst for a healthcare stock. It opens up new growth opportunities for the business.

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Here's why they think Eli Lilly (NYSE: LLY), Summit Therapeutics (NASDAQ: SMMT), and Vertex Pharmaceuticals (NASDAQ: VRTX) could trounce the market in 2025. David Jagielski (Eli Lilly): For years ...

Vertex Pharmaceuticals (NASDAQ: VRTX) has many promising treatments in its pipeline, as it looks to build out its business beyond just the cystic fibrosis (CF) drugs that have enabled it to post ...

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

An alarming video from Gaza shows young children handling oversized rifles in the absence of Hamas police. Despite Hamas's efforts to maintain order, children handling weapons instead of toys has ...

Tejashwi Yadav criticizes the newly appointed CEC, accusing the EC of bias towards the BJP and eroding public trust. He recalls alleged manipulation in the 2020 Bihar polls and vows to remove EVMs ...

Zoe Strimpel on the joys of seeing the world through the eyes of a nine-month-old.

Persistent Link: https://ieeexplore.ieee.org/servlet/opac?punumber=8016802 ...